Finance

Beta
Lists
002437:SHE
Harbin Gloria Pharmaceuticals Co., Ltd.
CN¥2.66
-1.85%
(-0.050) 1D
Jun 11, 3:04:45 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002437...
Open
CN¥2.69
High
CN¥2.71
Low
CN¥2.61
Mkt. cap
6.04B
Avg. vol.
60.17M
Volume
45.16M
P/E ratio
14.37
52-wk high
CN¥4.08
52-wk low
CN¥2.61
EPS
CN¥0.19
Shares outstanding
2.23B
No. of employees
2K
Open
CN¥2.69
High
CN¥2.71
Low
CN¥2.61
Mkt. cap
6.04B
Avg. vol.
60.17M
Volume
45.16M
P/E ratio
14.37
52-wk high
CN¥4.08
52-wk low
CN¥2.61
EPS
CN¥0.19
Shares outstanding
2.23B
No. of employees
2K
News stories
From sources across the web
About Harbin Gloria Pharmaceuticals Co., Ltd.
CEO-
Employees2.35K
FoundedMar 27, 2000
Headquarters-
SectorPharmaceutical industry
Websitegloria.cc
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
548.25M
565.50M
470.45M
539.11M
Cost of goods sold
298.78M
311.70M
276.98M
293.39M
Cost of revenue
298.78M
311.70M
276.98M
293.39M
Research and development expenses
15.27M
19.40M
28.71M
11.57M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
163.05M
146.28M
130.82M
149.91M
Operating expense
186.13M
174.42M
163.43M
169.75M
Total operating expenses
484.91M
486.12M
440.41M
463.14M
Operating income
63.34M
79.37M
30.05M
75.96M
Other non operating income
988.47K
-876.17K
990.79K
-1.24M
EBT including unusual items
83.14M
117.24M
140.28M
107.13M
EBT excluding unusual items
62.92M
80.36M
166.50M
75.62M
Income tax expense
7.65M
6.74M
5.85M
10.46M
Effective tax rate
9.20%
5.75%
4.17%
9.77%
Other operating expenses
7.76M
8.74M
3.78M
8.23M
Net income
74.17M
109.34M
133.14M
94.93M
Net profit margin
13.53%
19.34%
28.30%
17.61%
Earnings per share
-
-
-
-
Interest and investment income
1.12M
1.55M
137.90M
1.82M
Interest expense
-2.20M
-
-684.56K
-916.34K
Net interest expenses
-1.08M
1.55M
137.21M
906.81K
Depreciation and amortization charges
-
-
-
-
EBITDA
85.53M
102.03M
52.27M
98.18M
Gain or loss from assets sale
-3.60M
3.60M
-3.54M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more